Advanced search
1 file | 837.48 KB

Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates

Karen Couvreur (UGent) , Eline Naert (UGent) , Emiel De Jaeghere (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Pieter De Visschere (UGent) , Mieke Van Bockstal (UGent) , Jo Van Dorpe (UGent) , Wilfried De Neve (UGent) , Hannelore Denys (UGent) , et al.
(2018) BMC CANCER. 18.
Author
Organization
Keywords
Adenocarcinoma, Squamous cell carcinoma, Cervical cancer, Differences, Survival, Prognosis, MODULATED ARC THERAPY, STAGE IB, UTERINE CERVIX, ADENOSQUAMOUS CARCINOMAS, PROGNOSTIC-SIGNIFICANCE, RADICAL HYSTERECTOMY, CANCER, CHEMOTHERAPY, RADIOTHERAPY, SURGERY

Downloads

  • Neo-adjuvant treatment of adenocarcinoma and squamous cell carcionma of the cervix results in significantly different pathological complete response rates CouvreurNaertDeJaeghere.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 837.48 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Couvreur, Karen, Eline Naert, Emiel De Jaeghere, Philippe Tummers, Amin Makar, Pieter De Visschere, Mieke Van Bockstal, et al. 2018. “Neo-adjuvant Treatment of Adenocarcinoma and Squamous Cell Carcinoma of the Cervix Results in Significantly Different Pathological Complete Response Rates.” Bmc Cancer 18.
APA
Couvreur, K., Naert, E., De Jaeghere, E., Tummers, P., Makar, A., De Visschere, P., Van Bockstal, M., et al. (2018). Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates. BMC CANCER, 18.
Vancouver
1.
Couvreur K, Naert E, De Jaeghere E, Tummers P, Makar A, De Visschere P, et al. Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates. BMC CANCER. 2018;18.
MLA
Couvreur, Karen, Eline Naert, Emiel De Jaeghere, et al. “Neo-adjuvant Treatment of Adenocarcinoma and Squamous Cell Carcinoma of the Cervix Results in Significantly Different Pathological Complete Response Rates.” BMC CANCER 18 (2018): n. pag. Print.
@article{8580665,
  articleno    = {1101},
  author       = {Couvreur, Karen and Naert, Eline and De Jaeghere, Emiel and Tummers, Philippe and Makar, Amin and De Visschere, Pieter and Van Bockstal, Mieke and Van Dorpe, Jo and De Neve, Wilfried and Denys, Hannelore and Vandecasteele, Katrien},
  issn         = {1471-2407},
  journal      = {BMC CANCER},
  keyword      = {Adenocarcinoma,Squamous cell carcinoma,Cervical cancer,Differences,Survival,Prognosis,MODULATED ARC THERAPY,STAGE IB,UTERINE CERVIX,ADENOSQUAMOUS CARCINOMAS,PROGNOSTIC-SIGNIFICANCE,RADICAL HYSTERECTOMY,CANCER,CHEMOTHERAPY,RADIOTHERAPY,SURGERY},
  language     = {eng},
  pages        = {10},
  title        = {Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates},
  url          = {http://dx.doi.org/10.1186/s12885-018-5007-0},
  volume       = {18},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: